PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease.
Lee JS, Mukhopadhyay P, Matyas C, Trojnar E, Paloczi J, Yang YR, Blank BA, Savage C, Sorokin AV, Mehta NN, Vendruscolo JCM, Koob GF, Vendruscolo LF, Pacher P, Lohoff FW.
Lee JS, et al. Among authors: pacher p.
Sci Rep. 2019 Nov 20;9(1):17167. doi: 10.1038/s41598-019-53603-6.
Sci Rep. 2019.
PMID: 31748600
Free PMC article.